Pcdhb17 Inhibitors
Chemical inhibitors of Pcdhb17 can affect its function through various mechanisms involving the disruption of cellular structures and processes critical for its activity. Tetrodotoxin, through its inhibition of voltage-gated sodium channels, can prevent the generation and propagation of action potentials in neurons, where Pcdhb17 is expressed. This cessation of neuronal activity can lead to a decrease in the neuronal signaling that relies on Pcdhb17. Brefeldin A disrupts protein transport by inhibiting ADP-ribosylation factor, leading to potential mislocalization and subsequent dysfunction of Pcdhb17, which relies on precise localization for its role at the synapse. Latrunculin A and Cytochalasin D both target the actin cytoskeleton, with the former binding to actin monomers and the latter inhibiting their polymerization, resulting in the disruption of cytoskeletal dynamics. Since the actin cytoskeleton is essential for the cellular processes regulated by Pcdhb17, these disruptions can impair its function in cell-cell adhesion and signaling.
Colchicine and Nocodazole disrupt microtubule dynamics, the former by inhibiting tubulin polymerization and the latter by binding to β-tubulin. Both lead to a breakdown in intracellular transport systems, which are crucial for the function of Pcdhb17. On the other hand, Paclitaxel stabilizes microtubules but in doing so affects vesicle transport and cellular motility, which can indirectly inhibit Pcdhb17 function. Wiskostatin and Y-27632 inhibit regulators of actin polymerization, N-WASP, and ROCK, respectively. By disrupting actin polymerization, these inhibitors can affect synaptic localization and function of Pcdhb17. ML-7 and Blebbistatin target myosin-related processes; ML-7 inhibits myosin light chain kinase, while Blebbistatin inhibits myosin II ATPase activity. These disruptions can lead to impaired cellular movements and adhesion processes essential for Pcdhb17 function. Lastly, Endothall, as an ATPase inhibitor, disrupts cellular energy homeostasis, which is fundamental for ATP-dependent processes that Pcdhb17 requires for its role in cell adhesion and signaling.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts protein transport by inhibiting ADP-ribosylation factor, which could lead to mislocalization and dysfunction of Pcdhb17, as proper localization is crucial for its role in cell adhesion and signaling at the synapse. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A binds to actin monomers and prevents their polymerization, disrupting cytoskeletal dynamics. Since Pcdhb17 is involved in cell-cell adhesion, the disrupted actin cytoskeleton can impair the cellular processes that Pcdhb17 regulates. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine binds to tubulin, inhibiting its polymerization into microtubules, which can disrupt intracellular transport and localization of Pcdhb17, thereby inhibiting its function. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and prevents their disassembly, which can disrupt dynamic processes such as vesicle transport and cellular motility, indirectly inhibiting the function of Pcdhb17 by affecting cellular processes it is involved in. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Wiskostatin inhibits the activity of N-WASP, a critical regulator of actin polymerization. Disruption of actin polymerization can affect the synaptic localization and function of Pcdhb17, inhibiting its role in synapse formation and maintenance. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 is an inhibitor of myosin light chain kinase, which is involved in actin-myosin contraction. By inhibiting this kinase, ML-7 can disrupt cellular movements and processes that are essential for Pcdhb17-mediated cell-cell adhesion and signaling. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Blebbistatin inhibits myosin II ATPase activity, which can interfere with myosin-driven processes such as cell contractility and motility. This inhibition can consequently disrupt Pcdhb17's function in mediating cell adhesion and morphology. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 selectively inhibits ROCK, a Rho-associated protein kinase involved in actin cytoskeleton organization. Inhibition of ROCK can affect cell shape and motility, thereby potentially inhibiting Pcdhb17's function in cellular adhesion and signaling. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D inhibits actin polymerization and can lead to a breakdown of the actin cytoskeleton, which is necessary for Pcdhb17 to mediate cell-cell adhesion and signaling, thus inhibiting its function. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubule networks by binding to β-tubulin, which can lead to a failure in intracellular transport systems that are critical for the function of Pcdhb17, thereby inhibiting its role in cellular processes. | ||||||